Wellington Management Company »

Rapport Therapeutics shares owned by Wellington Management Company

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Wellington Management Company from 13F filings

Historical chart of Wellington Management Company investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Wellington Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Wellington Management Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.9M 63k 29.70

More positions owned by Wellington Management Company

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Mastercard Incorporated Cl A (MA)
Wells Fargo & Company (WFC)
Merck & Co (MRK)
UnitedHealth (UNH)
Johnson & Johnson (JNJ)
Sempra Energy (SRE)
JPMorgan Chase & Co. (JPM)

View all positions for Wellington Management Company

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Vanguard Group
Johnson & Johnson
Baker Bros. Advisors
Vestal Point Capital
Polar Capital Holdings
Trv Gp Vi
Ubs Global Asset Management Americas

View all funds holding Rapport Therapeutics